Groundwork BioAg

Mycorrhizal Inoculants and Premium Carbon Credits for Commercial Agriculture

Agriculture & Food Technologies
Private
Follow

Company Overview

Snapshot

Founded in April 2014 by Yossi Kofman, Dan Grotsky, and Danny Levy, Groundwork BioAg operates with 51–200 employees. The company has raised $41.2 million across 8 funding rounds from 15 investors.

Business overview

Groundwork BioAg develops mycorrhizal inoculants that enhance crop productivity, reduce fertilizer dependency, and enable verifiable carbon sequestration in agricultural soils. Its core product line, Rootella®, utilizes robust strains of mycorrhizal fungi to improve nutrient uptake, water efficiency, plant resilience, and soil carbon sequestration. The company's Rootella Carbon™ program allows farmers to generate premium carbon credits through durable soil carbon sequestration, certified by Verra. Groundwork BioAg's solutions are designed for seamless integration into both conventional and regenerative farming practices, serving the agriculture and food technologies sector.

Strategic signal

In January 2025, Groundwork BioAg partnered with Sustainable Travel International to offer carbon dioxide removal credits for tourism, signaling a strategic expansion beyond traditional agriculture into broader environmental markets. This move demonstrates the company's commitment to leveraging its mycorrhizal carbon technology for diverse applications and highlights its potential to contribute to global decarbonization efforts, attracting investors interested in scalable climate solutions.

Log in to access full profile

Company Intelligence Q&A

What was a significant recent product launch or program by Groundwork BioAg?
In October 2023, Groundwork BioAg globally launched the Rootella Carbon™ program. This initiative leverages mycorrhizal fungi as a nature-based solution for carbon dioxide removal, enabling farmers to generate premium carbon credits through verifiable soil carbon sequestration.
What was a key recent market expansion for Groundwork BioAg?
In December 2023, Groundwork BioAg announced that its Rootella mycorrhizal inoculant was approved for commercialization in China, Argentina, and South Africa. This expanded market access added approximately 677 million acres of harvested cropland to the company's potential customer base.
What was Groundwork BioAg's most recent funding activity?
This round was led by Climate Innovation Capital, with participation from Middleland Capital.
What recent strategic partnership did Groundwork BioAg announce for the Chinese market?
In January 2025, Groundwork BioAg and ADAMA announced an exclusive commercial agreement. This partnership aims to offer Rootella® inoculants to Chinese farmers, expanding the reach of the company's bioagriculture solutions in a key agricultural market.
Log in to access full profile